A Bioequivalence (BE) Study in Healthy Subjects

Clinical trial NCT01177943 · COMPLETED

Trial details

NCT number: NCT01177943
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder

Start date: 2010-08-01
Primary completion: 2010-10-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.